To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 118,746 shares, the number of shares held increased 6.73% compared to the previous period and now represents 2.45% of the total position.
      5.93K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 33,480 shares, the number of shares held increased 6.72% compared to the previous period and now represents 2.54% of the total position.
      384Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 50,274 shares, the number of shares held increased 6.73% compared to the previous period and now represents 1.7% of the total position.
      474Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 37,854 shares, the number of shares held increased 6.72% compared to the previous period and now represents 5.01% of the total position.
      193Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Freenome, Inc. by 48,276 shares, the number of shares held increased 6.73% compared to the previous period and now represents 0.57% of the total position.
      84Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 298,674 shares, the number of shares held increased 6.73% compared to the previous period and now represents 3.23% of the total position.
      158Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Absci Corporation. by 688,392 shares, the number of shares held increased 6.73% compared to the previous period and now represents 4.61% of the total position.
      69Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 711,288 shares, the number of shares held increased 6.73% compared to the previous period and now represents 0.71% of the total position.
      16.53K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 4,212 shares, the number of shares held increased 6.67% compared to the previous period and now represents 3.53% of the total position.
      84Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-20
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 80,460 shares, the number of shares held increased 6.73% compared to the previous period and now represents 9.03% of the total position.
      293Comment
      Report
       
       
       
       

      Most Discussed